DUOT Duos Technologies Group | $12.06 +6.5% | 6/15/2026 | | Boost Price Target | $17.00 ➝ $22.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 6/15/2026 |
KSCP Knightscope | $1.97 -0.4% | 6/15/2026 | | Lower Price Target | $26.00 ➝ $23.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 6/15/2026 |
QUBT Quantum Computing | $9.78 -3.4% | 6/15/2026 | | Boost Price Target | $27.00 ➝ $30.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 6/15/2026 |
AYTU Aytu BioPharma | $2.11 +1.5% | 6/11/2026 | | Boost Price Target | $14.00 ➝ $14.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 6/11/2026 |
OTLK Oncobiologics | $1.58 +0.4% | 6/11/2026 | | Boost Price Target | $6.00 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 6/11/2026 |
NTRP NextTrip | $2.03 -0.9% | 6/10/2026 | | Boost Price Target | $7.00 ➝ $7.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NextTrip (NASDAQ:NTRP) on 6/10/2026 |
SURG SurgePays | $0.45 +1.4% | 6/10/2026 | | Lower Price Target | $5.00 ➝ $3.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of SurgePays (NASDAQ:SURG) on 6/10/2026 |
ALLR Allarity Therapeutics | $1.32 -7.7% | 6/8/2026 | | Boost Price Target | $9.75 ➝ $10.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 6/8/2026 |
CING Cingulate | $5.01 +5.7% | 6/8/2026 | | Lower Price Target | $55.00 ➝ $52.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 6/8/2026 |
IGC IGC Pharma | $0.28 +0.5% | 6/8/2026 | | Boost Price Target | $5.25 ➝ $5.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 6/8/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
INTZ Intrusion | $0.81 +6.3% | 6/8/2026 | | Lower Price Target | $10.50 ➝ $9.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 6/8/2026 |
LUCD Lucid Diagnostics | $0.99 -2.9% | 6/8/2026 | | Boost Price Target | $9.00 ➝ $9.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 6/8/2026 |
MYO Myomo | $1.43 -6.3% | 6/8/2026 | | Boost Price Target | $9.50 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Myomo (NYSEAMERICAN:MYO) on 6/8/2026 |
PSTV Plus Therapeutics | $4.30 -5.8% | 6/8/2026 | | Lower Price Target | $65.00 ➝ $57.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 6/8/2026 |
GNSS Genasys | $1.69 -2.0% | 6/2/2026 | | Boost Price Target | $5.50 ➝ $6.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 6/2/2026 |
RNXT RenovoRx | $0.88 +0.5% | 6/1/2026 | | Boost Price Target | $13.50 ➝ $14.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 6/1/2026 |
AMTX Aemetis | $1.93 -0.8% | 5/22/2026 | | Boost Price Target | $21.00 ➝ $22.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 5/22/2026 |
TZOO Travelzoo | $10.59 -1.6% | 5/22/2026 | | Boost Price Target | $22.00 ➝ $23.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 5/22/2026 |
PDEX Pro-Dex | $60.46 -3.0% | 5/12/2026 | | Boost Price Target | $56.00 ➝ $70.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Pro-Dex (NASDAQ:PDEX) on 5/12/2026 |
NRXP NRx Pharmaceuticals | $4.03 +1.4% | 4/27/2026 | | Boost Price Target | $48.00 ➝ $49.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/27/2026 |
DUOT Duos Technologies Group | $12.06 +6.5% | 4/17/2026 | | Boost Price Target | $14.00 ➝ $17.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 4/17/2026 |
SURG SurgePays | $0.45 +1.4% | 4/17/2026 | | Lower Price Target | $9.75 ➝ $5.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of SurgePays (NASDAQ:SURG) on 4/17/2026 |
KSCP Knightscope | $1.97 -0.4% | 4/15/2026 | | Boost Price Target | $25.00 ➝ $26.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 4/15/2026 |
ALLR Allarity Therapeutics | $1.32 -7.7% | 4/10/2026 | | Boost Price Target | $9.50 ➝ $9.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 4/10/2026 |
ATOS Atossa Genetics | $1.97 -11.1% | 4/10/2026 | | Lower Price Target | $120.00 ➝ $24.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 4/10/2026 |
INTZ Intrusion | $0.81 +6.3% | 4/9/2026 | | Lower Price Target | $12.50 ➝ $10.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 4/9/2026 |
LUCD Lucid Diagnostics | $0.99 -2.9% | 4/9/2026 | | Boost Price Target | $8.25 ➝ $9.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 4/9/2026 |
PSTV Plus Therapeutics | $4.30 -5.8% | 4/9/2026 | | Lower Price Target | $475.00 ➝ $65.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 4/9/2026 |
RNXT RenovoRx | $0.88 +0.5% | 4/9/2026 | | Boost Price Target | $13.00 ➝ $13.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 4/9/2026 |
AMTX Aemetis | $1.93 -0.8% | 4/8/2026 | | Boost Price Target | $20.00 ➝ $21.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 4/8/2026 |
CING Cingulate | $5.01 +5.7% | 4/8/2026 | | Lower Price Target | $58.00 ➝ $55.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 4/8/2026 |
IGC IGC Pharma | $0.28 +0.5% | 4/8/2026 | | Boost Price Target | $5.00 ➝ $5.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 4/8/2026 |
GNSS Genasys | $1.69 -2.0% | 3/11/2026 | | Boost Price Target | $5.25 ➝ $5.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 3/11/2026 |
OTLK Oncobiologics | $1.58 +0.4% | 3/11/2026 | | Lower Price Target | $10.00 ➝ $6.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 3/11/2026 |
NTRP NextTrip | $2.03 -0.9% | 3/2/2026 | | Initiated Coverage | $7.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NextTrip (NASDAQ:NTRP) on 3/2/2026 |
IGC IGC Pharma | $0.28 +0.5% | 2/23/2026 | | Boost Price Target | $4.75 ➝ $5.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 2/23/2026 |
RNXT RenovoRx | $0.88 +0.5% | 2/17/2026 | | Boost Price Target | $12.50 ➝ $13.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 2/17/2026 |
NRXP NRx Pharmaceuticals | $4.03 +1.4% | 1/2/2026 | | Reiterated Rating | $47.00 ➝ $48.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 1/2/2026 |
DUOT Duos Technologies Group | $12.06 +6.5% | 12/30/2025 | | Boost Price Target | $11.50 ➝ $14.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 12/30/2025 |
GNSS Genasys | $1.69 -2.0% | 12/22/2025 | | Lower Price Target | $5.75 ➝ $5.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 12/22/2025 |
Iran War Shock: What I Was Told In That Private Meeting (Ad) You’re Being LIED To About The Iran War
Forget EVERYTHING you’ve heard about the Iran war.
Especially the reasons why we’re bombing the country. Because THIS is the real reason. |
OTLK Oncobiologics | $1.58 +0.4% | 12/22/2025 | | Boost Price Target | $8.00 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 12/22/2025 |
QUBT Quantum Computing | $9.78 -3.4% | 12/22/2025 | | Lower Price Target | $40.00 ➝ $25.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 12/22/2025 |
SURG SurgePays | $0.45 +1.4% | 12/22/2025 | | Boost Price Target | $9.50 ➝ $9.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of SurgePays (NASDAQ:SURG) on 12/22/2025 |
KSCP Knightscope | $1.97 -0.4% | 12/11/2025 | | Lower Price Target | $27.00 ➝ $25.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 12/11/2025 |
AYTU Aytu BioPharma | $2.11 +1.5% | 12/10/2025 | | Boost Price Target | $12.50 ➝ $13.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 12/10/2025 |
LUCD Lucid Diagnostics | $0.99 -2.9% | 12/10/2025 | | Boost Price Target | $8.00 ➝ $8.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 12/10/2025 |
ALLR Allarity Therapeutics | $1.32 -7.7% | 12/9/2025 | | Boost Price Target | $9.25 ➝ $9.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 12/9/2025 |
IGC IGC Pharma | $0.28 +0.5% | 12/9/2025 | | Boost Price Target | $4.50 ➝ $4.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 12/9/2025 |
ATOS Atossa Genetics | $1.97 -11.1% | 12/8/2025 | | Boost Price Target | $116.25 ➝ $120.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 12/8/2025 |
CING Cingulate | $5.01 +5.7% | 12/8/2025 | | Lower Price Target | $62.00 ➝ $58.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 12/8/2025 |
INTZ Intrusion | $0.81 +6.3% | 12/8/2025 | | Boost Price Target | $12.00 ➝ $12.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 12/8/2025 |
MYO Myomo | $1.43 -6.3% | 11/21/2025 | | Lower Price Target | $10.50 ➝ $10.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Myomo (NYSEAMERICAN:MYO) on 11/21/2025 |
PSTV Plus Therapeutics | $4.30 -5.8% | 11/21/2025 | | Lower Price Target | $525.00 ➝ $475.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 11/21/2025 |
RNXT RenovoRx | $0.88 +0.5% | 11/21/2025 | | Boost Price Target | $12.00 ➝ $12.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 11/21/2025 |
AMTX Aemetis | $1.93 -0.8% | 11/19/2025 | | Lower Price Target | $21.00 ➝ $20.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 11/19/2025 |
TZOO Travelzoo | $10.59 -1.6% | 11/19/2025 | | Lower Price Target | $26.00 ➝ $23.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 11/19/2025 |
NRXP NRx Pharmaceuticals | $4.03 +1.4% | 10/30/2025 | | Boost Price Target | $46.00 ➝ $47.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 10/30/2025 |
AMTX Aemetis | $1.93 -0.8% | 10/6/2025 | | Boost Price Target | $20.00 ➝ $21.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 10/6/2025 |
GNSS Genasys | $1.69 -2.0% | 10/6/2025 | | Boost Price Target | $5.50 ➝ $5.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 10/6/2025 |
INTZ Intrusion | $0.81 +6.3% | 10/6/2025 | | Boost Price Target | $11.00 ➝ $12.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 10/6/2025 |
KSCP Knightscope | $1.97 -0.4% | 10/6/2025 | | Boost Price Target | $26.00 ➝ $27.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 10/6/2025 |
LUCD Lucid Diagnostics | $0.99 -2.9% | 10/6/2025 | | Boost Price Target | $7.75 ➝ $8.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 10/6/2025 |
PSTV Plus Therapeutics | $4.30 -5.8% | 10/6/2025 | | Boost Price Target | $512.50 ➝ $525.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 10/6/2025 |
QUBT Quantum Computing | $9.78 -3.4% | 10/3/2025 | | Boost Price Target | $22.00 ➝ $40.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 10/3/2025 |
SURG SurgePays | $0.45 +1.4% | 10/3/2025 | | Boost Price Target | $9.00 ➝ $9.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of SurgePays (NASDAQ:SURG) on 10/3/2025 |
ALLR Allarity Therapeutics | $1.32 -7.7% | 9/26/2025 | | Boost Price Target | $9.00 ➝ $9.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 9/26/2025 |
AYTU Aytu BioPharma | $2.11 +1.5% | 9/25/2025 | | Boost Price Target | $12.00 ➝ $12.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 9/25/2025 |
DUOT Duos Technologies Group | $12.06 +6.5% | 9/24/2025 | | Boost Price Target | $11.00 ➝ $11.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 9/24/2025 |
ATOS Atossa Genetics | $1.97 -11.1% | 9/22/2025 | | Boost Price Target | $112.50 ➝ $116.25 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 9/22/2025 |
MYO Myomo | $1.43 -6.3% | 9/22/2025 | | Lower Price Target | $11.50 ➝ $10.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Myomo (NYSEAMERICAN:MYO) on 9/22/2025 |
OTLK Oncobiologics | $1.58 +0.4% | 9/22/2025 | | Lower Price Target | $21.00 ➝ $8.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 9/22/2025 |
IGC IGC Pharma | $0.28 +0.5% | 8/26/2025 | | Boost Price Target | $4.25 ➝ $4.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of IGC Pharma (NYSEAMERICAN:IGC) on 8/26/2025 |
TZOO Travelzoo | $10.59 -1.6% | 8/26/2025 | | Boost Price Target | $25.00 ➝ $26.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 8/26/2025 |
RNXT RenovoRx | $0.88 +0.5% | 8/25/2025 | | Boost Price Target | $11.50 ➝ $12.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 8/25/2025 |
CING Cingulate | $5.01 +5.7% | 8/22/2025 | | Boost Price Target | $61.00 ➝ $62.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 8/22/2025 |
ALLR Allarity Therapeutics | $1.32 -7.7% | 7/28/2025 | | Initiated Coverage | $9.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Allarity Therapeutics (NASDAQ:ALLR) on 7/28/2025 |
AYTU Aytu BioPharma | $2.11 +1.5% | 6/30/2025 | | Initiated Coverage | $12.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aytu BioPharma (NASDAQ:AYTU) on 6/30/2025 |
QMCO Quantum | $14.71 +2.1% | 6/18/2025 | | Reiterated Rating | | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum (NASDAQ:QMCO) on 6/18/2025 |
DUOT Duos Technologies Group | $12.06 +6.5% | 6/16/2025 | | Boost Price Target | $9.00 ➝ $11.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 6/16/2025 |
SURG SurgePays | $0.45 +1.4% | 6/16/2025 | | Boost Price Target | $8.75 ➝ $9.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of SurgePays (NASDAQ:SURG) on 6/16/2025 |
AMTX Aemetis | $1.93 -0.8% | 6/6/2025 | | Boost Price Target | $19.00 ➝ $20.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Aemetis (NASDAQ:AMTX) on 6/6/2025 |
ATOS Atossa Genetics | $1.97 -11.1% | 6/6/2025 | | Boost Price Target | $108.75 ➝ $112.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Atossa Genetics (NASDAQ:ATOS) on 6/6/2025 |
GNSS Genasys | $1.69 -2.0% | 6/6/2025 | | Lower Price Target | $6.00 ➝ $5.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Genasys (NASDAQ:GNSS) on 6/6/2025 |
KSCP Knightscope | $1.97 -0.4% | 6/6/2025 | | Lower Price Target | $30.00 ➝ $26.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 6/6/2025 |
LUCD Lucid Diagnostics | $0.99 -2.9% | 6/6/2025 | | Boost Price Target | $7.50 ➝ $7.75 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Lucid Diagnostics (NASDAQ:LUCD) on 6/6/2025 |
OTLK Oncobiologics | $1.58 +0.4% | 6/6/2025 | | Lower Price Target | $24.00 ➝ $21.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Oncobiologics (NASDAQ:OTLK) on 6/6/2025 |
PHUN Phunware | $1.95 -0.8% | 6/6/2025 | | Boost Price Target | $12.00 ➝ $12.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Phunware (NASDAQ:PHUN) on 6/6/2025 |
QUBT Quantum Computing | $9.78 -3.4% | 6/6/2025 | | Boost Price Target | $14.00 ➝ $22.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 6/6/2025 |
MYO Myomo | $1.43 -6.3% | 6/5/2025 | | Boost Price Target | $11.00 ➝ $11.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Myomo (NYSEAMERICAN:MYO) on 6/5/2025 |
PSTV Plus Therapeutics | $4.30 -5.8% | 6/5/2025 | | Boost Price Target | $500.00 ➝ $512.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Plus Therapeutics (NASDAQ:PSTV) on 6/5/2025 |
SpaceX will mint billionaires. You won't be one of them. (Ad) By the time a company goes public, 95% of the profits are typically already gone. SpaceX insiders bought in at a $20 billion valuation - you're being offered entry at $1.75 trillion.
But one small, publicly traded company sits directly in SpaceX's supply chain, still priced like Wall Street hasn't noticed. It powers critical infrastructure Musk's operation can't run without. Dylan Jovine is naming it today, free. Get the ticker before Wall Street connects the dots |
RNXT RenovoRx | $0.88 +0.5% | 6/5/2025 | | Boost Price Target | $11.00 ➝ $11.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of RenovoRx (NASDAQ:RNXT) on 6/5/2025 |
INTZ Intrusion | $0.81 +6.3% | 5/30/2025 | | Boost Price Target | $10.00 ➝ $11.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Intrusion (NASDAQ:INTZ) on 5/30/2025 |
TZOO Travelzoo | $10.59 -1.6% | 5/30/2025 | | Boost Price Target | $24.00 ➝ $25.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Travelzoo (NASDAQ:TZOO) on 5/30/2025 |
CING Cingulate | $5.01 +5.7% | 5/27/2025 | | Boost Price Target | $60.00 ➝ $61.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Cingulate (NASDAQ:CING) on 5/27/2025 |
COCH Envoy Medical | $0.65 +0.2% | 5/27/2025 | | Boost Price Target | $9.25 ➝ $9.50 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Envoy Medical (NASDAQ:COCH) on 5/27/2025 |
PDEX Pro-Dex | $60.46 -3.0% | 5/27/2025 | | Boost Price Target | $54.00 ➝ $56.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Pro-Dex (NASDAQ:PDEX) on 5/27/2025 |
NRXP NRx Pharmaceuticals | $4.03 +1.4% | 4/29/2025 | | Boost Price Target | $45.00 ➝ $46.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/29/2025 |
DUOT Duos Technologies Group | $12.06 +6.5% | 4/28/2025 | | Boost Price Target | $7.50 ➝ $9.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Duos Technologies Group (NASDAQ:DUOT) on 4/28/2025 |
KSCP Knightscope | $1.97 -0.4% | 4/28/2025 | | Lower Price Target | $32.00 ➝ $30.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Knightscope (NASDAQ:KSCP) on 4/28/2025 |
QUBT Quantum Computing | $9.78 -3.4% | 4/28/2025 | | Boost Price Target | $8.50 ➝ $14.00 | Buy | 00.00% | View details for Ascendiant Capital Markets rating of Quantum Computing (NASDAQ:QUBT) on 4/28/2025 |